Celsius Therapeutics - Ownership and Business Overview

Life ScienceCompany

Celsius Therapeutics Ownership

Who owns Celsius Therapeutics?

Celsius Therapeutics is owned by AbbVie. It was acquired on June 27, 2024.

Celsius Therapeutics Business Overview

Where is Celsius Therapeutics headquartered?

Celsius Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Celsius Therapeutics in?

Celsius Therapeutics is a life science company.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.

Celsius Therapeutics

Celsius Therapeutics, Inc.

245 First Street 18th Floor,
Cambridge, Massachusetts 02142
United States,
(857) 776-7400
www.celsiustx.com

Celsius Therapeutics is a clinical-stage biotechnology company developing novel medicines for inflammatory disease. The company's lead therapeutic candidate is an anti-TREM1 antibody for treating IBD. Celsius is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.